Ruben Mesa, M.D., is named director of UT Health Cancer Center
Ruben Mesa, M.D. (MED ’95, I ’98, HEMO ’02), has been named director of the UT Health Cancer Center in San Antonio, Texas, one of only four National Cancer Institute-designated Cancer Centers in Texas.
He has been a principal investigator or co-principal investigator of more than 70 clinical trials for patients and has led efforts in obtaining FDA approval for several new cancer drugs.
Formerly he was deputy director of the Mayo Clinic Cancer Center and chair of the Division of Hematology & Medical Oncology at Mayo Clinic in Arizona. He began his career in 1991 at Mayo Clinic in Rochester, where he worked for 18 years before moving eight years ago to Mayo Clinic in Arizona.
He has been involved in myeloproliferative neoplasm research for more than 20 years. He is chair of the National Comprehensive Cancer Network’s panel that published the first U.S. guidelines on the diagnosis and treatment of myelofibrosis in the Journal of the National Cancer Center Network in 2016. Dr. Mesa has more than 300 peer-reviewed scientific publications, has been principal or co-principal investigator of more than 70 clinical trials for patients with myeloproliferative neoplasms or other myeloid disorders.
Dr. Mesa has a bachelor’s degree in nuclear engineering and physiology from the University of Illinois at Urbana-Champaign. He received his medical degree, completed his residency in internal medicine and completed his fellowship in hematology/medical oncology from Mayo Clinic School of Graduate Medical Education in Rochester, Minnesota.